By synthesizing ApoE or ApoB amino acid fragments that bind to the low-density lipoprotein receptor (LRP) and conjugating them with our designed iron-chelating peptide J-bs5YP, we successfully transported the peptide into the brains of AD mice. This evidence concerns the gene APOE and Alzheimer disease.